References

American Heart Association website: http://www.americanheart.org

  • Beck E et al. Management of cluster headache. Am Fam Physician  2005; 71(4): 717-24.
  • Cagnacci A et al. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 2005 Dec; 18(12 Pt 1): 1614-18.
  • DeLeo V et al. Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. Maturitas  2001 Aug 25; 39(2): 185-88.
  • DeLeo V et al. Assessment of the association of kava-kava extract and hormone replacement therapy in the treatment of postmenopause anxiety. Minerva Ginecol 2000 Jun; 52(6): 263-67.
  • Dzugan, Sergey. The Migraine Cure.  St. Paul: Dragon Door Publications, 2006.
  • Dzugan SA, Smith AR. Hypercholesterolemia treatment: a new hypothesis or just an accident? Med Hypotheses 2002; Dec; 59(6): 751-56.
  • Eli R. Fasciano JA. A chronopharmacological preventive treatment for sleep-related migraine headaches and chronic morning headaches: nitric oxide supersensitivity can cause sleep-related headaches in a subset of patients. Med Hypotheses 2006; 66(3) 461-65.
  • Fidan I et al. The importance of cytokines, chemokines and  nitric oxide in pathophysiology of migraine. J Neuroimmunol  2006 Feb; 171(1-2): 184-88.
  • Kasper DL, Braunwald DE et al. Harrison’s Principles of Internal Medicine.  16th ed. New York: McGraw-Hill Professional, 2005.
  • Leone M, D’Amico D, et al. Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia 1996; 16:494-96.
  • Lipton RB et al. Prevalence and burden of migraine in the United States: results from the American Migraine Study II. Headache 2001; 41:646-57.
  • Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998; 38:87-96.
  • Lipton RB, Scher AI, et al. Migraine in the United States. Neurology 2002; 58:885.
  • Lipton R, Stewart WF. Migraine in the Untied States: a review of epidemiology and health care use. Neurology  1993; 43:S6-S10.
  • Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. Med Clin North Am 2001; 85:911.
  • Pittler MH, Ernst E. Kava extract for treating anxiety. Cochran Database Syst Rev 2002; (2): CD003393.
  • Rude RK. Magnesium deficiency: A cause of heterogeneous disease in humans. J Bone Miner Res 1998; 13:749-58.
  • Sargeant L et al. Headache, Cluster. March 10, 2005; article at www.emedicine.com/EMERG/topic229.htm
  • Scheer FA et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension  2004 Feb; 43(2): 192-97.

 

Start the Program
Click Here